The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The maximal affinity of ligands
Open accessAbstract
We explore the question of what are the best ligands for macromolecular targets. A survey of experimental data on a large number of the strongest-binding ligands indicates that the free energy of binding increases with the number of nonhydrogen atoms with an initial slope of ≈−1.5 kcal/mol (1 cal = 4.18 J) per atom. For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative molecular mass. This nonlinearity is largely ascribed to nonthermodynamic factors. An analysis of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands. Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin–avidin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00124a002 · Cited by 13,103
Self-citationLipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,827
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Tanford, C. (1980) · Cited by 1,903
Enzyme catalysis: not different, just better
Knowles, J. R. (1991) · Nature · doi:10.1038/350121a0 · Cited by 567
Functional group contributions to drug-receptor interactions
Andrews, P. R., Craik, D. J., & Martin, J. L. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a021 · Cited by 535
Reconciling the Magnitude of the Microscopic and Macroscopic Hydrophobic Effects
Sharp, K. A., Nicholls, A., Fine, R. F., & Honig, B. (1991) · Science · doi:10.1126/science.2011744 · Cited by 512
Self-citationCan We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Surface topography dependence of biomolecular hydrophobic hydration
Cheng, Y.-K., & Rossky, P. J. (1998) · Nature · doi:10.1038/33653 · Cited by 394
Kim, E. E., Baker, C. T., Dwyer, M. D., Murcko, M. A., Rao, B. G., Tung, R. D., & Navia, M. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00108a056 · Cited by 390
Additivity principles in biochemistry.
Dill, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.701 · Cited by 347
Bergstrom, J. D., Kurtz, M. M., Rew, D. J., Amend, A. M., Karkas, J. D., Bostedor, R. G., Bansal, V. S., Dufresne, C., VanMiddlesworth, F. L., & Hensens, O. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.80 · Cited by 335
DeWitte, R. S., & Shakhnovich, E. I. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960751u · Cited by 262
Holloway, M. K., Wai, J. M., Halgren, T. A., Fitzgerald, P. M. D., Vacca, J. P., Dorsey, B. D., Levin, R. B., Thompson, W. J., & Chen, L. J. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a012 · Cited by 232
Miyamoto, S., & Kollman, P. A. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160303 · Cited by 225
Self-citationEisen, M. B., Wiley, D. C., Karplus, M., & Hubbard, R. E. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190305 · Cited by 210
Bohacek, R. S., & McMartin, C. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00092a006 · Cited by 188
Handbook of enzyme inhibitors (1965–1977)
(1983) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(83)90119-6 · Cited by 184
Lam, P. Y. S., Ru, Y., Jadhav, P. K., Aldrich, P. E., DeLucca, G. V., Eyermann, C. J., Chang, C.-H., Emmett, G., Holler, E. R., Daneker, W. F., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602571 · Cited by 173
Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D
Kick, E. K., Roe, D. C., Skillman, A. G., Liu, G., Ewing, T. J. A., Sun, Y., Kuntz, I. D., & Ellman, J. A. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90073-9 · Cited by 161
Self-citationDesign, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease
Webber, S. E., Tikhe, J. G., Worland, S. T., Fuhrman, S. A., Hendrickson, T. F., Matthews, D. A., Love, R. A., Patick, A. K., Meador, J. W., Ferre, R. A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960603e · Cited by 159
Design of potent selective zinc-mediated serine protease inhibitors
Katz, B. A., Clark, J. M., Finer-Moore, J. S., Jenkins, T. E., Johnson, C. R., Ross, M. J., Luong, C., Moore, W. R., & Stroud, R. M. (1998) · Nature · doi:10.1038/35422 · Cited by 150
What determines the strength of noncovalent association of ligands to proteins in aqueous solution?
Miyamoto, S., & Kollman, P. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8402 · Cited by 144
Self-citationDevelopment of Potent Thrombin Receptor Antagonist Peptides
Bernatowicz, M. S., Klimas, C. E., Hartl, K. S., Peluso, M., Allegretto, N. J., & Seiler, S. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960455s · Cited by 144
von Itzstein, M., Dyason, J. C., Oliver, S. W., White, H. F., Wu, W.-Y., Kok, G. B., & Pegg, M. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950294c · Cited by 115
Computation of electrostatic complements to proteins: A case of charge stabilized binding
Chong, L. T., Dempster, S. E., Hendsch, Z. S., Lee, L., & Tidor, B. (1998) · Protein Science · doi:10.1002/pro.5560070122 · Cited by 85
Spadoni, G., Stankov, B. M., Duranti, A., Biella, G. E. M., Lucini, V., Salvatori, A., & FRASCHINI, F. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00077a010 · Cited by 82
Rogers, G. A., Kornreich, W. D., Hand, K., et al. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13235-5 · Cited by 41
Cited by
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
Benchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318
Metadata
- Authors
- Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-31
- Volume
- 96
- Issue
- 18
- Pages
- 9997-10002
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2127073449
- Cited by
- 849
- References
- 30
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.